New Talent Is In At Sanofi, Biogen
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi appointed immunology expert Yong-Jun Liu as head of research, leaving a vacancy at Medimmune, while Biogen recruited its new chief commercial officer Michel Vounatsos from Merck.
You may also be interested in...
Sanofi R&D Chief Zerhouni: How I'm Doing More With Less
Elias Zerhouni says Sanofi's ongoing R&D revamp has produced improved innovative results with controlled spending, in part by emphasizing cutting-edge product development ahead of research.
Merck & Co. Remains 'Very Confident' In TIGIT
Despite initial underwhelming competitive data on the cancer target, Merck said it is expanding its investment behind its anti-TIGIT drug vibostolimab. Roche updated investors on its program too.
From Hallelujah To Headwind: Pfizer's COVID-19 Franchise Hits The Downturn
Pfizer expects Comirnaty and Paxlovid revenues to be drastically lower this year after pushing 2022 revenues over $100bn. Management said 2023 would be a transition year for the company.